Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review

BACKGROUND: Bevacizumab combined with chemotherapy has become the first-line therapy in advanced nonsquamous non-small-cell lung cancer (NSCLC). However, few studies have focused on cisplatin/pemetrexed with bevacizumab as the first-line therapy to treat advanced nonsquamous NSCLC. Importantly, whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiyong, Zhu, Hui, Kong, Li, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968850/
https://www.ncbi.nlm.nih.gov/pubmed/27555784
http://dx.doi.org/10.2147/OTT.S101241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968850/
https://www.ncbi.nlm.nih.gov/pubmed/27555784
http://dx.doi.org/10.2147/OTT.S101241

Ejemplares similares